All Stories

  1. Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United States
  2. Recruitment and retention of pediatric participants for pandemic preparedness research: Experience from the PREMISE EV-D68 Pilot Study
  3. Predicting the impact of non-pharmaceutical interventions against COVID-19 onMycoplasma pneumoniaein the United States
  4. Multimodal Surveillance Model for Enterovirus D68 Respiratory Disease and Acute Flaccid Myelitis among Children in Colorado, USA, 2022
  5. Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
  6. Acute flaccid myelitis in low- to middle-income countries: diagnosis and surveillance
  7. Gaps in diagnosing suspected infection in immunocompromised children with cancer: A systematic review
  8. Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA
  9. Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship
  10. Qualitative detection of enterovirus D68 from PrimeStore® molecular transport medium: implications for home- and self-collection
  11. Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
  12. Plasma Microbial Cell-Free DNA Sequencing from over 15,000 Patients Identified a Broad Spectrum of Pathogens
  13. Shifting Epidemiology and Severity of Respiratory Syncytial Virus in Children During the COVID-19 Pandemic
  14. Perspectives on Diagnosis and Management of All-Cause Encephalitis: A National Survey of Adult Infectious Diseases Physicians
  15. Acute Liver Failure in a Child With Adenovirus Detected by PCR in the Explanted Liver
  16. Plasma Microbial Cell-free DNA Sequencing from Over 15,000 Patients Identified a Broad Spectrum of Pathogens
  17. Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption
  18. Clinical and Financial Impact of a Diagnostic Stewardship Program for Children with Suspected Central Nervous System Infection
  19. Preventing enterovirus A71 disease: another promising vaccine for children
  20. Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens
  21. Metagenomic Next-Generation Sequencing for Diagnosis of Pediatric Meningitis and Encephalitis: A Review
  22. AKI In Suspected Meningitis/Encephalitis May Be “Avoidable Kidney Injury”
  23. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis
  24. Acute flaccid myelitis: cause, diagnosis, and management
  25. Variability in the Use of Novel Diagnostic Technology in Children With Suspected Encephalitis and in the Management of Emerging Encephalitides by Pediatric Infectious Disease Providers
  26. Foreign Body Esophageal Perforation Leading to Multifocal Brain Abscesses: A Case Report
  27. Enterovirus D68 Subclade B3 in Children with Acute Flaccid Paralysis in West Africa, 2016
  28. Evaluation for Arboviral Infection Among Children Hospitalized in Colorado With Aseptic Meningitis and Encephalitis
  29. Impact of FilmArray meningitis encephalitis panel on HSV testing and empiric acyclovir use in children beyond the neonatal period
  30. Epidemiological dynamics of enterovirus D68 in the US: implications for acute flaccid myelitis
  31. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study
  32. Two Blood Cultures With Age-Appropriate Volume Enhance Suspected Sepsis Decision-Making
  33. A Resident-Based, Educational Program to Drive Individual and Institutional Improvement in a Pediatric Training Hospital
  34. Pan-viral serology implicates enteroviruses in acute flaccid myelitis
  35. Acute Flaccid Myelitis Surveillance: A Signal Through the Noise
  36. Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review
  37. Gastroenteritis, Hepatitis, Encephalopathy, and Human Herpesvirus 6 Detection in an Immunocompetent Child: Benefits and Risks of Syndromic Multiplex Molecular Panel Testing
  38. Incidence, Risk Factors and Outcomes Among Children With Acute Flaccid Myelitis: A Population-based Cohort Study in a California Health Network Between 2011 and 2016
  39. Picornavirus etiology of acute infections among hospitalized infants
  40. Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
  41. Serological and metagenomic interrogation of cerebrospinal fluid implicates enteroviruses in pediatric acute flaccid myelitis
  42. Neonatal parechovirus infection mimicking a surgical abdomen
  43. Acute Flaccid Myelitis Associated With Enterovirus D68: A Review
  44. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid
  45. Continued biennial circulation of enterovirus D68 in Colorado
  46. Enterovirus D68–Associated Acute Flaccid Myelitis
  47. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
  48. Acute Flaccid Myelitis—Keys to Diagnosis, Questions About Treatment, and Future Directions
  49. Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016
  50. Rapid identification of nonblood sterile site broth cultures using the FilmArray blood culture identification panel
  51. Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016–2017 Season
  52. Blood PCR testing for enteroviruses in young children
  53. Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis
  54. Letter to the editor: economic analysis lacks external validity to support universal syndromic testing for suspected meningitis/encephalitis
  55. A 4-Year-Old Boy With an Unusual Bacterial Meningitis Infection
  56. Notes from the Field: Enterovirus A71 Neurologic Disease in Children — Colorado, 2018
  57. Enterovirus D68 can cause acute flaccid myelitis
  58. Laboratory Validation of a Clinical Metagenomic Sequencing Assay for Pathogen Detection in Cerebrospinal Fluid
  59. Narrow-spectrum, compared with broad-spectrum, antibiotics equally effective with less adverse events
  60. Encephalitis in US Children
  61. A Child With Intermittent Headaches and Eosinophilic Meningitis
  62. Reply to “Integrated Stewardship Model Comprising Antimicrobial, Infection Prevention, and Diagnostic Stewardship (AID Stewardship)”
  63. The changing epidemiology of acute flaccid paralysis warrants a paradigm shift in surveillance
  64. Surveillance for enterovirus D68 in colorado children reveals continued circulation
  65. Outcomes of Colorado children with acute flaccid myelitis at 1 year
  66. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala
  67. Antimicrobial stewardship increases ID consults
  68. Diagnostic and Antimicrobial Stewardship for Rapid ID Diagnostics
  69. Enterovirus D68 in Critically Ill Children
  70. Impact of New Rapid CSF Diagnostic Test
  71. Clinical Impact and Provider Acceptability of Real-Time Antimicrobial Stewardship Decision Support for Rapid Diagnostics in Children With Positive Blood Culture Results
  72. A new densovirus in cerebrospinal fluid from a case of anti-NMDA-receptor encephalitis
  73. Acute Flaccid Myelitis Review
  74. Case Control Study of EV-D68 and AFM in CO
  75. Hospitalized Children With Encephalitis in the United States: A Pediatric Health Information System Database Study
  76. Do epidural fevers contribute to babies receiving antibiotics?
  77. Improvement of Abandonment of Therapy in Pediatric Patients with Cancer in Guatemala
  78. The Unmeasured Burden of Enterovirus D68 in 2014
  79. Erratum to: Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing
  80. The Emergence of Enterovirus-D68
  81. Abnormal Neuroimaging in a Case of Infant Botulism
  82. Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing
  83. 2014 Enterovirus D68 Outbreak
  84. Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the critical need for reference strain sequencing
  85. Enterovirus D68 and Acute Flaccid Myelitis in CO 2014
  86. Cluster of Acute Flaccid Myelitis and Enterovirus D68 in CO 2014
  87. Epidemiology and clinical characteristics of infants with human parechovirus or human herpes virus-6 detected in cerebrospinal fluid tested for enterovirus or herpes simplex virus
  88. MRI Findings in Children with Acute Flaccid Paralysis and Cranial Nerve Dysfunction Occurring during the 2014 Enterovirus D68 Outbreak
  89. Neuroinvasive Arboviral Disease in the United States: 2003 to 2012
  90. Bacteriology and Risk Factors for Development of Late (Greater Than One Year) Deep Infection Following Spinal Fusion With Instrumentation
  91. Diffuse Nodular Lung Infiltrates in a Well Appearing Three-Year-Old Boy With Recurrent Sinopulmonary Infections and Parotitis
  92. Severe neuroinvasive West Nile virus infection in a child with undiagnosed Addison's disease
  93. Rhino/enteroviruses in hospitalized children: A comparison to influenza viruses